STATE OF WISCONSIN INVESTMENT BOARD - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 216 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,686,973
-52.6%
201,791
+40.9%
0.01%
-50.0%
Q2 2023$3,556,815
+85.6%
143,189
+12.4%
0.01%
+66.7%
Q1 2023$1,915,991
+17.0%
127,393
-8.0%
0.01%
+20.0%
Q4 2022$1,637,390
+13.4%
138,410
-43.2%
0.01%0.0%
Q3 2022$1,444,000
+19.4%
243,874
-14.3%
0.01%
+66.7%
Q2 2022$1,209,000
-42.1%
284,558
+29.5%
0.00%
-25.0%
Q1 2022$2,089,000
-32.9%
219,700
+34.1%
0.00%
-33.3%
Q4 2021$3,112,000
-42.9%
163,8000.0%0.01%
-45.5%
Q3 2021$5,451,000
-19.0%
163,800
-5.6%
0.01%
-21.4%
Q2 2021$6,730,000
-18.2%
173,500
+1.6%
0.01%
-22.2%
Q1 2021$8,228,000
-2.7%
170,700
+5.0%
0.02%
-10.0%
Q4 2020$8,453,000
+88.7%
162,500
-2.9%
0.02%
+81.8%
Q3 2020$4,480,000
+45.2%
167,400
+5.7%
0.01%
+22.2%
Q2 2020$3,086,000
+135.9%
158,400
+19.2%
0.01%
+125.0%
Q1 2020$1,308,000
-0.1%
132,900
+12.7%
0.00%
+33.3%
Q4 2019$1,309,000
+97.7%
117,9000.0%0.00%
+50.0%
Q3 2019$662,000
-10.8%
117,900
+37.4%
0.00%0.0%
Q2 2019$742,000
+9.9%
85,800
+2.3%
0.00%0.0%
Q1 2019$675,000
+153.8%
83,900
+29.5%
0.00%
+100.0%
Q4 2018$266,000
-21.3%
64,800
+7.5%
0.00%0.0%
Q3 2018$338,000
-57.4%
60,3000.0%0.00%
-50.0%
Q2 2018$793,000
+36.3%
60,300
+47.1%
0.00%0.0%
Q1 2018$582,000
+73.2%
41,0000.0%0.00%
+100.0%
Q4 2017$336,000
-30.9%
41,0000.0%0.00%0.0%
Q3 2017$486,000
+18.0%
41,0000.0%0.00%0.0%
Q2 2017$412,00041,0000.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 5,434,783$60,326,0005.25%
RA Capital Management 9,880,323$109,672,0003.33%
BRIDGER MANAGEMENT, LLC 1,907,492$21,173,0001.53%
Eversept Partners, LP 776,323$8,617,1851.52%
Opaleye Management Inc. 579,651$6,434,0001.26%
Sofinnova Investments, Inc. 811,292$9,006,0000.65%
Ikarian Capital, LLC 316,200$3,510,0000.57%
ARMISTICE CAPITAL, LLC 800,000$8,880,0000.51%
683 Capital Management, LLC 398,271$4,421,0000.51%
Frontier Wealth Management LLC 196,750$2,184,0000.35%
View complete list of TG THERAPEUTICS INC shareholders